Nutrisystem on Thursday announced that in order to meet growing consumer demand for its Nutrisystem D 5-Day Jumpstart Weight Loss Kit, the company has ramped up production and will offer its product in 3,700 Walmart stores by the end of June.
With renewed consumer confidence converting more shoppers into buyers, there is greater opportunity for companies in the health and wellness space, noted a report titled "The Why Behind the Buy Spring 2013," which was released recently by Acosta Sales and Marketing.
Whole Foods Market is celebrating Hemp History Week, which is a nationwide education campaign that runs from June 3 to 9 to raise awareness about the benefits of hemp products, by spotlighting more than 300 hemp products, including body care products.
Retail pharmacists will be missing out on as much as a $20 billion opportunity if they don't identify how to consistently and efficiently engage their patients, suggested Jeff Rehling, principal at Edgewood Consulting Group, during a business session Sunday at the recent 2013 GMDC Health & Wellness @ Retail Conference.
The year is only halfway done, but 2013 is already proving to be a year of particular importance for generic drugs as the industry awaits two important decisions from the Supreme Court and continues to wait for federal biosimilar regulations while fending off efforts to limit the scope of their use at the state level.
NBTY, a manufacturer and distributor of vitamins, supplements and sports nutrition, announced last week that it will donate nearly $500,000 of Good 'n Natural bars, Balance Bars and bottles of children's gummy vitamins to support tornado relief efforts in Oklahoma.
Beyond Meat, the makers of plant-based protein foods that take the animal out of meat, announced the national rollout of Beyond Meat Chicken-Free Strips to provide consumers with a clean, plant-based protein that replicates the taste, texture and nutritional benefits of meat.
Last month, the Supreme Court heard Federal Trade Commission v. Actavis, which could impact the future of the generic drug industry at a time when 80% of all prescriptions dispensed in the United States are generic.